{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T19:43:21Z","timestamp":1774035801270,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T00:00:00Z","timestamp":1512518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00467-017-3850-x","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T08:46:56Z","timestamp":1512550016000},"page":"379-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Shiga toxin triggers endothelial and podocyte injury: the role of complement activation"],"prefix":"10.1007","volume":"34","author":[{"given":"Carlamaria","family":"Zoja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Buelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Morigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"key":"3850_CR1","first-page":"1073","volume":"365","author":"PI Tarr","year":"2005","unstructured":"Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia Coli and haemolytic uraemic syndrome. Lancet 365:1073\u20131086","journal-title":"Lancet"},{"key":"3850_CR2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","volume":"16","author":"M Noris","year":"2005","unstructured":"Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16:1035\u20131050","journal-title":"J Am Soc Nephrol"},{"key":"3850_CR3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.vetmic.2009.04.011","volume":"140","author":"MA Karmali","year":"2010","unstructured":"Karmali MA, Gannon V, Sargeant JM (2010) Verocytotoxin-producing Escherichia Coli (VTEC). Vet Microbiol 140:360\u2013370","journal-title":"Vet Microbiol"},{"key":"3850_CR4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/joim.12546","volume":"281","author":"D Karpman","year":"2017","unstructured":"Karpman D, Loos S, Tati R, Arvidsson I (2017) Haemolytic uraemic syndrome. J Intern Med 281:123\u2013148","journal-title":"J Intern Med"},{"key":"3850_CR5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","volume":"60","author":"P Ruggenenti","year":"2001","unstructured":"Ruggenenti P, Noris M, Remuzzi G (2001) Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60:831\u2013846","journal-title":"Kidney Int"},{"key":"3850_CR6","doi-asserted-by":"publisher","unstructured":"Rivas M, Chinen I, Miliwebsky E, Masana M (2014) Risk factors for Shiga toxin-producing Escherichia Coli-associated human diseases. Microbiol Spectr 2. https:\/\/doi.org\/10.1128\/microbiolspec.EHEC-0002-2013","DOI":"10.1128\/microbiolspec.EHEC-0002-2013"},{"key":"3850_CR7","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00467-012-2383-6","volume":"28","author":"JM Spinale","year":"2013","unstructured":"Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS (2013) Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol 28:2097\u20132105","journal-title":"Pediatr Nephrol"},{"key":"3850_CR8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jpeds.2014.12.064","volume":"166","author":"RK Mody","year":"2015","unstructured":"Mody RK, Gu W, Griffin PM, Jones TF, Rounds J, Shiferaw B, Tobin-D'Angelo M, Smith G, Spina N, Hurd S, Lathrop S, Palmer A, Boothe E, Luna-Gierke RE, Hoekstra RM (2015) Postdiarrheal hemolytic uremic syndrome in United States children: clinical spectrum and predictors of in-hospital death. J Pediatr 166:1022\u20131029","journal-title":"J Pediatr"},{"key":"3850_CR9","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","volume":"290","author":"AX Garg","year":"2003","unstructured":"Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clark WF (2003) Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290:1360\u20131370","journal-title":"JAMA"},{"key":"3850_CR10","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/cis196","volume":"54","author":"A Rosales","year":"2012","unstructured":"Rosales A, Hofer J, Zimmerhackl LB, Jungraithmayr TC, Riedl M, Giner T, Strasak A, Orth-Holler D, Wurzner R, Karch H (2012) Need for long-term follow-up in enterohemorrhagic Escherichia Coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis 54:1413\u20131421","journal-title":"Clin Infect Dis"},{"key":"3850_CR11","doi-asserted-by":"crossref","unstructured":"Bitzan M (2009) Treatment options for HUS secondary to Escherichia Coli O157:H7. Kidney Int Suppl:S62\u2013S66","DOI":"10.1038\/ki.2008.624"},{"key":"3850_CR12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MNH.0b013e328354a62e","volume":"21","author":"TN Petruzziello-Pellegrini","year":"2012","unstructured":"Petruzziello-Pellegrini TN, Marsden PA (2012) Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics. Curr Opin Nephrol Hypertens 21:433\u2013440","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3850_CR13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","volume":"390","author":"F Fakhouri","year":"2017","unstructured":"Fakhouri F, Zuber J, Fremeaux-Bacchi V, Loirat C (2017) Haemolytic uraemic syndrome. Lancet 390:681\u2013696","journal-title":"Lancet"},{"key":"3850_CR14","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1056\/NEJMoa1106482","volume":"365","author":"U Buchholz","year":"2011","unstructured":"Buchholz U, Bernard H, Werber D, Bohmer MM, Remschmidt C, Wilking H, Delere Y, an der Heiden M, Adlhoch C, Dreesman J, Ehlers J, Ethelberg S, Faber M, Frank C, Fricke G, Greiner M, Hohle M, Ivarsson S, Jark U, Kirchner M, Koch J, Krause G, Luber P, Rosner B, Stark K, Kuhne M (2011) German outbreak of Escherichia Coli O104:H4 associated with sprouts. N Engl J Med 365:1763\u20131770","journal-title":"N Engl J Med"},{"key":"3850_CR15","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1106483","volume":"365","author":"C Frank","year":"2011","unstructured":"Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Muller L, King LA, Rosner B, Buchholz U, Stark K, Krause G (2011) Epidemic profile of Shiga-toxin-producing Escherichia Coli O104:H4 outbreak in Germany. N Engl J Med 365:1771\u20131780","journal-title":"N Engl J Med"},{"key":"3850_CR16","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","volume":"364","author":"AL Lapeyraque","year":"2011","unstructured":"Lapeyraque AL, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M, Proulx F, Clermont MJ, Le Deist F, Niaudet P, Schaefer F (2011) Eculizumab in severe Shiga-Toxin-Associated HUS. N Engl J Med 364:2561\u20132563","journal-title":"N Engl J Med"},{"key":"3850_CR17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4565","volume":"345","author":"J Menne","year":"2012","unstructured":"Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmuller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, Munte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Schocklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellhoner P, Wiesner M, Zeissig S, Buning J, Schiffer M, Kuehbacher T (2012) Validation of treatment strategies for enterohaemorrhagic Escherichia Coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 345:e4565","journal-title":"BMJ"},{"key":"3850_CR18","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","volume":"27","author":"JT Kielstein","year":"2012","unstructured":"Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, Nurnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R (2012) Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-Toxin-Producing E. Coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant 27:3807\u20133815","journal-title":"Nephrol Dial Transplant"},{"key":"3850_CR19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrneph.2012.194","volume":"8","author":"P Ruggenenti","year":"2012","unstructured":"Ruggenenti P, Remuzzi G (2012) Thrombotic microangiopathy: E. Coli O104:H4 German outbreak: a missed opportunity. Nat Rev Nephrol 8:558\u2013560","journal-title":"Nat Rev Nephrol"},{"key":"3850_CR20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0009922814534520","volume":"54","author":"A Saini","year":"2015","unstructured":"Saini A, Emke AR, Silva MC, Perlman SJ (2015) Response to Eculizumab in Escherichia Coli O157: H7-induced hemolytic uremic syndrome with severe neurological manifestations. Clin Pediatr (Phila) 54:387\u2013389","journal-title":"Clin Pediatr (Phila)"},{"key":"3850_CR21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001000","volume":"94","author":"L Pape","year":"2015","unstructured":"Pape L, Hartmann H, Bange FC, Suerbaum S, Bueltmann E, Ahlenstiel-Grunow T (2015) Eculizumab in typical Hemolytic uremic syndrome (HUS) with neurological involvement. Medicine (Baltimore) 94:e1000","journal-title":"Medicine (Baltimore)"},{"key":"3850_CR22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ndt\/gft470","volume":"29","author":"Y Delmas","year":"2014","unstructured":"Delmas Y, Vendrely B, Clouzeau B, Bachir H, Bui HN, Lacraz A, Helou S, Bordes C, Reffet A, Llanas B, Skopinski S, Rolland P, Gruson D, Combe C (2014) Outbreak of Escherichia Coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab. Nephrol Dial Transplant 29:565\u2013572","journal-title":"Nephrol Dial Transplant"},{"key":"3850_CR23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1473-3099(11)70165-7","volume":"11","author":"M Bielaszewska","year":"2011","unstructured":"Bielaszewska M, Mellmann A, Zhang W, Kock R, Fruth A, Bauwens A, Peters G, Karch H (2011) Characterisation of the Escherichia Coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 11:671\u2013676","journal-title":"Lancet Infect Dis"},{"key":"3850_CR24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(11)61217-8","volume":"378","author":"P Ruggenenti","year":"2011","unstructured":"Ruggenenti P, Remuzzi G (2011) A German outbreak of haemolytic uraemic syndrome. Lancet 378:1057\u20131058","journal-title":"Lancet"},{"key":"3850_CR25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11908-012-0302-4","volume":"15","author":"S Hauswaldt","year":"2013","unstructured":"Hauswaldt S, Nitschke M, Sayk F, Solbach W, Knobloch JK (2013) Lessons learned from outbreaks of Shiga toxin producing Escherichia Coli. Curr Infect Dis Rep 15:4\u20139","journal-title":"Curr Infect Dis Rep"},{"key":"3850_CR26","doi-asserted-by":"crossref","unstructured":"Karmali MA (2009) Host and pathogen determinants of verocytotoxin-producing Escherichia Coli-associated hemolytic uremic syndrome. Kidney Int Suppl:S4\u2013S7","DOI":"10.1038\/ki.2008.608"},{"key":"3850_CR27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cid\/ciw708","volume":"64","author":"MA Karmali","year":"2017","unstructured":"Karmali MA (2017) Emerging public health challenges of Shiga toxin-producing Escherichia Coli related to changes in the pathogen, the population, and the environment. Clin Infect Dis 64:371\u2013376","journal-title":"Clin Infect Dis"},{"key":"3850_CR28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1462-5822.2007.01103.x","volume":"10","author":"G Frankel","year":"2008","unstructured":"Frankel G, Phillips AD (2008) Attaching effacing Escherichia Coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cell Microbiol 10:549\u2013556","journal-title":"Cell Microbiol"},{"key":"3850_CR29","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00467-010-1522-1","volume":"25","author":"C Zoja","year":"2010","unstructured":"Zoja C, Buelli S, Morigi M (2010) Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatr Nephrol 25:2231\u20132240","journal-title":"Pediatr Nephrol"},{"key":"3850_CR30","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1111\/j.1742-4658.2010.07653.x","volume":"277","author":"KG Campellone","year":"2010","unstructured":"Campellone KG (2010) Cytoskeleton-modulating effectors of enteropathogenic and enterohaemorrhagic Escherichia Coli: Tir, EspFU and actin pedestal assembly. FEBS J 277:2390\u20132402","journal-title":"FEBS J"},{"key":"3850_CR31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00018-012-1060-z","volume":"70","author":"A Bauwens","year":"2013","unstructured":"Bauwens A, Betz J, Meisen I, Kemper B, Karch H, Muthing J (2013) Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature. Cell Mol Life Sci 70:425\u2013457","journal-title":"Cell Mol Life Sci"},{"key":"3850_CR32","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1523-1755.2002.00502.x","volume":"62","author":"NW Rutjes","year":"2002","unstructured":"Rutjes NW, Binnington BA, Smith CR, Maloney MD, Lingwood CA (2002) Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model. Kidney Int 62:832\u2013845","journal-title":"Kidney Int"},{"key":"3850_CR33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2005-08-3219","volume":"108","author":"AL Stahl","year":"2006","unstructured":"Stahl AL, Svensson M, Morgelin M, Svanborg C, Tarr PI, Mooney JC, Watkins SL, Johnson R, Karpman D (2006) Lipopolysaccharide from enterohemorrhagic Escherichia Coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 108:167\u2013176","journal-title":"Blood"},{"key":"3850_CR34","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1128\/IAI.60.4.1536-1543.1992","volume":"60","author":"CB Louise","year":"1992","unstructured":"Louise CB, Obrig TG (1992) Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 60:1536\u20131543","journal-title":"Infect Immun"},{"key":"3850_CR35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1159\/000088523","volume":"25","author":"F Clayton","year":"2005","unstructured":"Clayton F, Pysher TJ, Lou R, Kohan DE, Denkers ND, Tesh VL, Taylor FB Jr, Siegler RL (2005) Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndrome. Am J Nephrol 25:536\u2013540","journal-title":"Am J Nephrol"},{"key":"3850_CR36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00467-003-1395-7","volume":"19","author":"M Ikeda","year":"2004","unstructured":"Ikeda M, Ito S, Honda M (2004) Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin. Pediatr Nephrol 19:485\u2013489","journal-title":"Pediatr Nephrol"},{"key":"3850_CR37","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1681\/ASN.2006050419","volume":"17","author":"TR Keepers","year":"2006","unstructured":"Keepers TR, Psotka MA, Gross LK, Obrig TG (2006) A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 17:3404\u20133414","journal-title":"J Am Soc Nephrol"},{"key":"3850_CR38","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4049\/jimmunol.181.2.1460","volume":"181","author":"C Zanchi","year":"2008","unstructured":"Zanchi C, Zoja C, Morigi M, Valsecchi F, Liu XY, Rottoli D, Locatelli M, Buelli S, Pezzotta A, Mapelli P, Geelen J, Remuzzi G, Hawiger J (2008) Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin. J Immunol 181:1460\u20131469","journal-title":"J Immunol"},{"key":"3850_CR39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/INF.0b013e3182074d22","volume":"30","author":"M Brigotti","year":"2011","unstructured":"Brigotti M, Tazzari PL, Ravanelli E, Carnicelli D, Rocchi L, Arfilli V, Scavia G, Minelli F, Ricci F, Pagliaro P, Ferretti AV, Pecoraro C, Paglialonga F, Edefonti A, Procaccino MA, Tozzi AE, Caprioli A (2011) Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome. Pediatr Infect Dis J 30:486\u2013490","journal-title":"Pediatr Infect Dis J"},{"key":"3850_CR40","first-page":"105","volume":"357","author":"TG Obrig","year":"2012","unstructured":"Obrig TG, Karpman D (2012) Shiga toxin pathogenesis: kidney complications and renal failure. Curr Top Microbiol Immunol 357:105\u2013136","journal-title":"Curr Top Microbiol Immunol"},{"key":"3850_CR41","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.1300122","volume":"191","author":"M Brigotti","year":"2013","unstructured":"Brigotti M, Carnicelli D, Arfilli V, Tamassia N, Borsetti F, Fabbri E, Tazzari PL, Ricci F, Pagliaro P, Spisni E, Cassatella MA (2013) Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils. J Immunol 191:4748\u20134758","journal-title":"J Immunol"},{"key":"3850_CR42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004619","volume":"11","author":"AL Stahl","year":"2015","unstructured":"Stahl AL, Arvidsson I, Johansson KE, Chromek M, Rebetz J, Loos S, Kristoffersson AC, Bekassy ZD, Morgelin M, Karpman D (2015) A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles. PLoS Pathog 11:e1004619","journal-title":"PLoS Pathog"},{"key":"3850_CR43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1160\/TH08-05-0317","volume":"101","author":"J Muthing","year":"2009","unstructured":"Muthing J, Schweppe CH, Karch H, Friedrich AW (2009) Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb Haemost 101:252\u2013264","journal-title":"Thromb Haemost"},{"key":"3850_CR44","first-page":"65","volume":"180","author":"AD O'Brien","year":"1992","unstructured":"O'Brien AD, Tesh VL, Donohue-Rolfe A, Jackson MP, Olsnes S, Sandvig K, Lindberg AA, Keusch GT (1992) Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol 180:65\u201394","journal-title":"Curr Top Microbiol Immunol"},{"key":"3850_CR45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0966-842X(96)10017-2","volume":"4","author":"CA Lingwood","year":"1996","unstructured":"Lingwood CA (1996) Role of verotoxin receptors in pathogenesis. Trends Microbiol 4:147\u2013153","journal-title":"Trends Microbiol"},{"key":"3850_CR46","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/358510a0","volume":"358","author":"K Sandvig","year":"1992","unstructured":"Sandvig K, Garred O, Prydz K, Kozlov JV, Hansen SH, van Deurs B (1992) Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358:510\u2013512","journal-title":"Nature"},{"key":"3850_CR47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1432-1033.1988.tb13756.x","volume":"171","author":"Y Endo","year":"1988","unstructured":"Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K (1988) Site of action of a Vero toxin (VT2) from Escherichia Coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171:45\u201350","journal-title":"Eur J Biochem"},{"key":"3850_CR48","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4161\/viru.26143","volume":"4","author":"TN Petruzziello-Pellegrini","year":"2013","unstructured":"Petruzziello-Pellegrini TN, Moslemi-Naeini M, Marsden PA (2013) New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome. Virulence 4:556\u2013563","journal-title":"Virulence"},{"key":"3850_CR49","first-page":"137","volume":"357","author":"VL Tesh","year":"2012","unstructured":"Tesh VL (2012) The induction of apoptosis by Shiga toxins and ricin. Curr Top Microbiol Immunol 357:137\u2013178","journal-title":"Curr Top Microbiol Immunol"},{"key":"3850_CR50","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1182\/blood.V86.12.4553.bloodjournal86124553","volume":"86","author":"M Morigi","year":"1995","unstructured":"Morigi M, Micheletti G, Figliuzzi M, Imberti B, Karmali MA, Remuzzi A, Remuzzi G, Zoja C (1995) Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. Blood 86:4553\u20134558","journal-title":"Blood"},{"key":"3850_CR51","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1523-1755.2002.00503.x","volume":"62","author":"C Zoja","year":"2002","unstructured":"Zoja C, Angioletti S, Donadelli R, Zanchi C, Tomasoni S, Binda E, Imberti B, te Loo M, Monnens L, Remuzzi G, Morigi M (2002) Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int 62:846\u2013856","journal-title":"Kidney Int"},{"key":"3850_CR52","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1182\/blood-2002-10-3301","volume":"102","author":"A Matussek","year":"2003","unstructured":"Matussek A, Lauber J, Bergau A, Hansen W, Rohde M, Dittmar KE, Gunzer M, Mengel M, Gatzlaff P, Hartmann M, Buer J, Gunzer F (2003) Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells. Blood 102:1323\u20131332","journal-title":"Blood"},{"key":"3850_CR53","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1182\/blood.V98.6.1828","volume":"98","author":"M Morigi","year":"2001","unstructured":"Morigi M, Galbusera M, Binda E, Imberti B, Gastoldi S, Remuzzi A, Zoja C, Remuzzi G (2001) Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. Blood 98:1828\u20131835","journal-title":"Blood"},{"key":"3850_CR54","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1172\/JCI57313","volume":"122","author":"TN Petruzziello-Pellegrini","year":"2012","unstructured":"Petruzziello-Pellegrini TN, Yuen DA, Page AV, Patel S, Soltyk AM, Matouk CC, Wong DK, Turgeon PJ, Fish JE, Ho JJ, Steer BM, Khajoee V, Tigdi J, Lee WL, Motto DG, Advani A, Gilbert RE, Karumanchi SA, Robinson LA, Tarr PI, Liles WC, Brunton JL, Marsden PA (2012) The CXCR4\/CXCR7\/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest 122:759\u2013776","journal-title":"J Clin Invest"},{"key":"3850_CR55","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ (2001) Complement. First of two parts. N Engl J Med 344:1058\u20131066","journal-title":"N Engl J Med"},{"key":"3850_CR56","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel PF, Skerka C (2009) Complement regulators and inhibitory proteins. Nat Rev Immunol 9:729\u2013740","journal-title":"Nat Rev Immunol"},{"key":"3850_CR57","first-page":"168","volume":"13","author":"L Monnens","year":"1980","unstructured":"Monnens L, Molenaar J, Lambert PH, Proesmans W, van Munster P (1980) The complement system in hemolytic-uremic syndrome in childhood. Clin Nephrol 13:168\u2013171","journal-title":"Clin Nephrol"},{"key":"3850_CR58","first-page":"126","volume":"21","author":"FT Koster","year":"1984","unstructured":"Koster FT, Boonpucknavig V, Sujaho S, Gilman RH, Rahaman MM (1984) Renal histopathology in the hemolytic-uremic syndrome following shigellosis. Clin Nephrol 21:126\u2013133","journal-title":"Clin Nephrol"},{"key":"3850_CR59","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000187063","volume":"62","author":"WL Robson","year":"1992","unstructured":"Robson WL, Leung AK, Fick GH, McKenna AI (1992) Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome. Nephron 62:296\u2013299","journal-title":"Nephron"},{"key":"3850_CR60","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","volume":"4","author":"JM Thurman","year":"2009","unstructured":"Thurman JM, Marians R, Emlen W, Wood S, Smith C, Akana H, Holers VM, Lesser M, Kline M, Hoffman C, Christen E, Trachtman H (2009) Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:1920\u20131924","journal-title":"Clin J Am Soc Nephrol"},{"key":"3850_CR61","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/cei.12601","volume":"181","author":"JR Ferraris","year":"2015","unstructured":"Ferraris JR, Ferraris V, Acquier AB, Sorroche PB, Saez MS, Ginaca A, Mendez CF (2015) Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome. Clin Exp Immunol 181:118\u2013125","journal-title":"Clin Exp Immunol"},{"key":"3850_CR62","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","volume":"117","author":"AL Stahl","year":"2011","unstructured":"Stahl AL, Sartz L, Karpman D (2011) Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia Coli-induced hemolytic uremic syndrome. Blood 117:5503\u20135513","journal-title":"Blood"},{"key":"3850_CR63","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.4049\/jimmunol.1402470","volume":"194","author":"I Arvidsson","year":"2015","unstructured":"Arvidsson I, Stahl AL, Hedstrom MM, Kristoffersson AC, Rylander C, Westman JS, Storry JR, Olsson ML, Karpman D (2015) Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome. J Immunol 194:2309\u20132318","journal-title":"J Immunol"},{"key":"3850_CR64","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4049\/jimmunol.1502377","volume":"197","author":"I Arvidsson","year":"2016","unstructured":"Arvidsson I, Rebetz J, Loos S, Herthelius M, Kristoffersson AC, Englund E, Chromek M, Karpman D (2016) Early terminal complement blockade and C6 deficiency are protective in Enterohemorrhagic Escherichia Coli-infected mice. J Immunol 197:1276\u20131286","journal-title":"J Immunol"},{"key":"3850_CR65","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1111\/ajt.12297","volume":"13","author":"M Alberti","year":"2013","unstructured":"Alberti M, Valoti E, Piras R, Bresin E, Galbusera M, Tripodo C, Thaiss F, Remuzzi G, Noris M (2013) Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations. Am J Transplant 13:2201\u20132206","journal-title":"Am J Transplant"},{"key":"3850_CR66","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","volume":"182","author":"D Orth","year":"2009","unstructured":"Orth D, Khan AB, Naim A, Grif K, Brockmeyer J, Karch H, Joannidis M, Clark SJ, Day AJ, Fidanzi S, Stoiber H, Dierich MP, Zimmerhackl LB, Wurzner R (2009) Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol 182:6394\u20136400","journal-title":"J Immunol"},{"key":"3850_CR67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molimm.2013.11.009","volume":"58","author":"K Poolpol","year":"2014","unstructured":"Poolpol K, Orth-Holler D, Speth C, Zipfel PF, Skerka C, de Cordoba SR, Brockmeyer J, Bielaszewska M, Wurzner R (2014) Interaction of Shiga toxin 2 with complement regulators of the factor H protein family. Mol Immunol 58:77\u201384","journal-title":"Mol Immunol"},{"key":"3850_CR68","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/IAI.01079-12","volume":"81","author":"S Ehrlenbach","year":"2013","unstructured":"Ehrlenbach S, Rosales A, Posch W, Wilflingseder D, Hermann M, Brockmeyer J, Karch H, Satchell SC, Wurzner R, Orth-Holler D (2013) Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells. Infect Immun 81:2678\u20132685","journal-title":"Infect Immun"},{"key":"3850_CR69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074880","volume":"8","author":"W Dammermann","year":"2013","unstructured":"Dammermann W, Schipper P, Ullrich S, Fraedrich K, Schulze Zur Wiesch J, Frundt T, Tiegs G, Lohse A, Luth S (2013) Increased expression of complement regulators CD55 and CD59 on peripheral blood cells in patients with EAHEC O104:H4 infection. PLoS One 8:e74880","journal-title":"PLoS One"},{"key":"3850_CR70","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","volume":"187","author":"M Morigi","year":"2011","unstructured":"Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C (2011) Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 187:172\u2013180","journal-title":"J Immunol"},{"key":"3850_CR71","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1681\/ASN.2013050450","volume":"25","author":"M Locatelli","year":"2014","unstructured":"Locatelli M, Buelli S, Pezzotta A, Corna D, Perico L, Tomasoni S, Rottoli D, Rizzo P, Conti D, Thurman JM, Remuzzi G, Zoja C, Morigi M (2014) Shiga toxin promotes podocyte injury in experimental Hemolytic uremic syndrome via activation of the alternative pathway of complement. J Am Soc Nephrol 25:1786\u20131798","journal-title":"J Am Soc Nephrol"},{"key":"3850_CR72","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.4049\/jimmunol.1100280","volume":"187","author":"D Iwaki","year":"2011","unstructured":"Iwaki D, Kanno K, Takahashi M, Endo Y, Matsushita M, Fujita T (2011) The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway. J Immunol 187:3751\u20133758","journal-title":"J Immunol"},{"key":"3850_CR73","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.kint.2016.05.011","volume":"90","author":"M Ozaki","year":"2016","unstructured":"Ozaki M, Kang Y, Tan YS, Pavlov VI, Liu B, Boyle DC, Kushak RI, Skjoedt MO, Grabowski EF, Taira Y, Stahl GL (2016) Human mannose-binding lectin inhibitor prevents Shiga toxin-induced renal injury. Kidney Int 90:774\u2013782","journal-title":"Kidney Int"},{"key":"3850_CR74","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.4049\/jimmunol.1102118","volume":"189","author":"C Zoja","year":"2012","unstructured":"Zoja C, Locatelli M, Pagani C, Corna D, Zanchi C, Isermann B, Remuzzi G, Conway EM, Noris M (2012) Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in mice. J Immunol 189:3661\u20133668","journal-title":"J Immunol"},{"key":"3850_CR75","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1096\/fasebj.9.10.7615164","volume":"9","author":"CT Esmon","year":"1995","unstructured":"Esmon CT (1995) Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9:946\u2013955","journal-title":"FASEB J"},{"key":"3850_CR76","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","volume":"361","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM (2009) Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 361:345\u2013357","journal-title":"N Engl J Med"},{"key":"3850_CR77","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00467-003-1236-8","volume":"18","author":"GC Fernandez","year":"2003","unstructured":"Fernandez GC, Te Loo MW, van der Velden TJ, van der Heuvel LP, Palermo MS, Monnens LL (2003) Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome. Pediatr Nephrol 18:1066\u20131068","journal-title":"Pediatr Nephrol"},{"key":"3850_CR78","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20041497","volume":"201","author":"I Conde Del","year":"2005","unstructured":"Del Conde I, Cruz MA, Zhang H, Lopez JA, Afshar-Kharghan V (2005) Platelet activation leads to activation and propagation of the complement system. J Exp Med 201:871\u2013879","journal-title":"J Exp Med"},{"key":"3850_CR79","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0038-1655974","volume":"77","author":"K Ikeda","year":"1997","unstructured":"Ikeda K, Nagasawa K, Horiuchi T, Tsuru T, Nishizaka H, Niho Y (1997) C5a induces tissue factor activity on endothelial cells. Thromb Haemost 77:394\u2013398","journal-title":"Thromb Haemost"},{"key":"3850_CR80","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1084\/jem.185.9.1619","volume":"185","author":"F Tedesco","year":"1997","unstructured":"Tedesco F, Pausa M, Nardon E, Introna M, Mantovani A, Dobrina A (1997) The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med 185:1619\u20131627","journal-title":"J Exp Med"},{"key":"3850_CR81","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fj.02-0737com","volume":"17","author":"T Monsinjon","year":"2003","unstructured":"Monsinjon T, Gasque P, Chan P, Ischenko A, Brady JJ, Fontaine MC (2003) Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J 17:1003\u20131014","journal-title":"FASEB J"},{"key":"3850_CR82","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4049\/jimmunol.169.4.2102","volume":"169","author":"IU Schraufstatter","year":"2002","unstructured":"Schraufstatter IU, Trieu K, Sikora L, Sriramarao P, DiScipio R (2002) Complement c3a and c5a induce different signal transduction cascades in endothelial cells. J Immunol 169:2102\u20132110","journal-title":"J Immunol"},{"key":"3850_CR83","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1523-1755.2001.060003957.x","volume":"60","author":"YH Kim","year":"2001","unstructured":"Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L, Kershaw D, Wiggins R (2001) Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 60:957\u2013968","journal-title":"Kidney Int"},{"key":"3850_CR84","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2353\/ajpath.2006.050398","volume":"168","author":"D Macconi","year":"2006","unstructured":"Macconi D, Bonomelli M, Benigni A, Plati T, Sangalli F, Longaretti L, Conti S, Kawachi H, Hill P, Remuzzi G, Remuzzi A (2006) Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol 168:42\u201354","journal-title":"Am J Pathol"},{"key":"3850_CR85","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.ki.5002222","volume":"71","author":"RC Wiggins","year":"2007","unstructured":"Wiggins RC (2007) The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71:1205\u20131214","journal-title":"Kidney Int"},{"key":"3850_CR86","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1681\/ASN.2014080752","volume":"26","author":"JB Hodgin","year":"2015","unstructured":"Hodgin JB, Bitzer M, Wickman L, Afshinnia F, Wang SQ, O'Connor C, Yang Y, Meadowbrooke C, Chowdhury M, Kikuchi M, Wiggins JE, Wiggins RC (2015) Glomerular aging and focal global glomerulosclerosis: a podometric perspective. J Am Soc Nephrol 26:3162\u20133178","journal-title":"J Am Soc Nephrol"},{"key":"3850_CR87","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1159\/000101793","volume":"106","author":"CB Marshall","year":"2007","unstructured":"Marshall CB, Shankland SJ (2007) Cell cycle regulatory proteins in podocyte health and disease. Nephron Exp Nephrol 106:e51\u2013e59","journal-title":"Nephron Exp Nephrol"},{"key":"3850_CR88","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.ajpath.2013.06.033","volume":"183","author":"H Liapis","year":"2013","unstructured":"Liapis H, Romagnani P, Anders HJ (2013) New insights into the pathology of podocyte loss: mitotic catastrophe. Am J Pathol 183:1364\u20131374","journal-title":"Am J Pathol"},{"key":"3850_CR89","first-page":"315","volume-title":"Hemolytic uremic syndrome and thrombotic thrombocytopenic Purpura","author":"R Habib","year":"1992","unstructured":"Habib R (1992) Pathology of the Hemolytic uremic syndrome. In: Kaplan BS, Trompeter RS, Moake JL (eds) Hemolytic uremic syndrome and thrombotic thrombocytopenic Purpura. Marcel Dekker, Inc., New York, pp 315\u2013353"},{"key":"3850_CR90","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/08860220600778902","volume":"28","author":"L Petris De","year":"2006","unstructured":"De Petris L, Patrick J, Christen E, Trachtman H (2006) Urinary podocyte mRNA excretion in children with D+HUS: a potential marker of long-term outcome. Ren Fail 28:475\u2013482","journal-title":"Ren Fail"},{"key":"3850_CR91","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0002-9440(10)65380-1","volume":"154","author":"FB Taylor Jr","year":"1999","unstructured":"Taylor FB Jr, Tesh VL, DeBault L, Li A, Chang AC, Kosanke SD, Pysher TJ, Siegler RL (1999) Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol 154:1285\u20131299","journal-title":"Am J Pathol"},{"key":"3850_CR92","first-page":"29","volume":"5","author":"F Ochoa","year":"2012","unstructured":"Ochoa F, Oltra G, Gerhardt E, Hermes R, Cohen L, Damiano AE, Ibarra C, Lago NR, Zotta E (2012) Microalbuminuria and early renal response to lethal dose Shiga toxin type 2 in rats. Int J Nephrol Renov Dis 5:29\u201336","journal-title":"Int J Nephrol Renov Dis"},{"key":"3850_CR93","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2353\/ajpath.2006.051331","volume":"169","author":"M Morigi","year":"2006","unstructured":"Morigi M, Buelli S, Zanchi C, Longaretti L, Macconi D, Benigni A, Moioli D, Remuzzi G, Zoja C (2006) Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling. Am J Pathol 169:1965\u20131975","journal-title":"Am J Pathol"},{"key":"3850_CR94","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1046\/j.1523-1755.2000.00095.x","volume":"57","author":"AK Hughes","year":"2000","unstructured":"Hughes AK, Stricklett PK, Schmid D, Kohan DE (2000) Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. Kidney Int 57:2350\u20132359","journal-title":"Kidney Int"},{"key":"3850_CR95","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00467-002-1025-9","volume":"18","author":"Z Ergonul","year":"2003","unstructured":"Ergonul Z, Clayton F, Fogo AB, Kohan DE (2003) Shigatoxin-1 binding and receptor expression in human kidneys do not change with age. Pediatr Nephrol 18:246\u2013253","journal-title":"Pediatr Nephrol"},{"key":"3850_CR96","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/IAI.01591-14","volume":"82","author":"AK Dettmar","year":"2014","unstructured":"Dettmar AK, Binder E, Greiner FR, Liebau MC, Kurschat CE, Jungraithmayr TC, Saleem MA, Schmitt CP, Feifel E, Orth-Holler D, Kemper MJ, Pepys M, Wurzner R, Oh J (2014) Protection of human podocytes from shiga toxin 2-induced phosphorylation of mitogen-activated protein kinases and apoptosis by human serum amyloid P component. Infect Immun 82:1872\u20131879","journal-title":"Infect Immun"},{"key":"3850_CR97","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000045953","volume":"88","author":"AK Hughes","year":"2001","unstructured":"Hughes AK, Stricklett PK, Kohan DE (2001) Shiga toxin-1 regulation of cytokine production by human glomerular epithelial cells. Nephron 88:14\u201323","journal-title":"Nephron"},{"key":"3850_CR98","doi-asserted-by":"crossref","first-page":"28445","DOI":"10.1038\/srep28445","volume":"6","author":"M Morigi","year":"2016","unstructured":"Morigi M, Locatelli M, Rota C, Buelli S, Corna D, Rizzo P, Abbate M, Conti D, Perico L, Longaretti L, Benigni A, Zoja C, Remuzzi G (2016) A previously unrecognized role of C3a in proteinuric progressive nephropathy. Sci Rep 6:28445","journal-title":"Sci Rep"},{"key":"3850_CR99","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.metabol.2015.01.014","volume":"64","author":"L Li","year":"2015","unstructured":"Li L, Chen L, Zang J, Tang X, Liu Y, Zhang J, Bai L, Yin Q, Lu Y, Cheng J, Fu P, Liu F (2015) C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt\/beta-catenin signaling pathway in diabetic kidney disease. Metabolism 64:597\u2013610","journal-title":"Metabolism"},{"key":"3850_CR100","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrd4657","volume":"14","author":"BP Morgan","year":"2015","unstructured":"Morgan BP, Harris CL (2015) Complement, a target for therapy in inflammatory and degenerative diseases. Nat Rev Drug Discov 14:857\u2013877","journal-title":"Nat Rev Drug Discov"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3850-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3850-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3850-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T21:41:10Z","timestamp":1603489270000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3850-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,6]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3850"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3850-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,6]]},"assertion":[{"value":"29 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}